AGN 196996 is primarily utilized in the field of ophthalmology for its potential therapeutic effects. It is studied for its ability to modulate specific biological pathways that are involved in the treatment of eye disorders. Researchers are particularly interested in its application for managing conditions like glaucoma, where it may help in reducing intraocular pressure. Additionally, it is being explored for its role in promoting retinal health and potentially aiding in the treatment of retinal degenerative diseases. The compound's mechanism of action targets key molecular processes, making it a candidate for further development in ocular therapeutics.